BCV Asset Management Inc.
Source: SEC Form 13F · as of Mar 2026BCV Asset Management Inc. holds 9 biotech & pharma companies tracked by BioSniper, totaling $196.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$196.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ELI LILLY & Co (LLY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 82,923 | $76.3M |
| ABBVAbbVie Inc. | 335,274 | $72.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 155,355 | $42.0M |
| MOHMolina Healthcare Inc | 36,942 | $4.9M |
| JNJJOHNSON & JOHNSON | 1,633 | $399K |
| CINGCingulate Inc. | 51,200 | $318K |
| ACHVACHIEVE LIFE SCIENCES, INC. | 26,365 | $78K |
| GOSSGossamer Bio, Inc. | 106,500 | $35K |
| LEXXLexaria Bioscience Corp. | 10,000 | $8K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.